Skip to content

miRNA?lncRNA and cir-RNA express in the T-cell lymphoma leukemia of children

miRNA?lncRNA and cir-RNA express in the T-cell lymphoma leukemia of children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039255
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-10-15
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T-cell lymphoma leukemia of children

Interventions

good prognosis group vs. poor prognosis group:N/A

Sponsors

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1. The age of children with T-ALL was less than 15 years old, and there was no chromosome abnormality at the first diagnosis. 2. The inclusion criteria of group A with good prognosis: 2014.1-2019.6, disease-free survival >= 3 years, initial stage medium to high risk group; 3. The inclusion criteria of group B with poor prognosis: 2014.1-2019.6, disease-free survival < 3 years, initial stage medium to high risk group; 4. Validation specimens: the children with T-ALL, aged < 15 years old, had no chromosome abnormality at the time of initial diagnosis.

Exclusion criteria

Exclusion criteria: 1. There is no initial sample; 2. No follow-up treatment; 3. Subjects with incomplete medical history; 4. Patients give up treatment automatically; 5. Death and other accidents not caused by the disease itself.

Design outcomes

Primary

MeasureTime frame
miRNA;lncRNA;cirRNA;

Countries

China

Contacts

Public ContactWu Xia

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

272240324@qq.com+86 18256027965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026